Author(s):
Trupti M. Rajamanya, Yogesh S. Thorat, Avinash H. Hosmani, Vaijinath G. Digge
Email(s):
triptirajamanya@gmail.com
DOI:
10.52711/0974-360X.2024.00766 
Address:
Trupti M. Rajamanya*1, Yogesh S. Thorat2, Avinash H. Hosmani3, Vaijinath G. Digge4
1Research Scholar, Punyashlok Ahilyadevi Holkar Solapur University, Solapur, Maharashtra, India.
2Associate Professor, Department of Pharmaceutics, D.S.T.S. Mandal’s College of Pharmacy, Solapur, Maharashtra, India.
3Associate Professor, Government College of Pharmacy, Karad, Maharashtra, India.
4Principal, Allamprabhu College of Pharmacy, Latur, Maharashtra, India.
*Corresponding Author
Published In:
Volume - 17,
Issue - 10,
Year - 2024
ABSTRACT:
The objective of the current work is to develop an ion activated in situ gel for treatment of Glaucoma with Brimonidine Tartrate. As conventional eye drops exhibit the demerits of poor bioavailability, naso-lachrymal drainage and rapid pre-corneal elimination, it was proposed that ion activated ophthalmic in situ gel formulation approach can be used to address these issues. The gels were formulated using 32 factorial design by cold method using sodium alginate as gelling agent in the concentration of 1%, 1.25% and 1.5 %. HPMC K4M and Carbobol 971 P were used as mucoadhesive agent to increase ocular residence. The evaluation of the prepared formulations was done for appearance, gel strength, mucoadhesion, viscosity, gelation, pH, drug content, sterility and in vitro diffusion. The ocular irritancy test was done by HET CAM test as well as the results show that the prepared in situ gel formulation exhibit sustained drug release up to 6 hours with excellent mucoadhesion which can achieve the objective of better ocular bioavailability.
Cite this article:
Trupti M. Rajamanya, Yogesh S. Thorat, Avinash H. Hosmani, Vaijinath G. Digge. Formulation and Evaluation of Ion Activated In-Situ Gelling Ophthalmic Solution containing Brimonidine Tartrate using 32 Factorial Design. Research Journal of Pharmacy and Technology. 2024; 17(10):4981-0. doi: 10.52711/0974-360X.2024.00766
Cite(Electronic):
Trupti M. Rajamanya, Yogesh S. Thorat, Avinash H. Hosmani, Vaijinath G. Digge. Formulation and Evaluation of Ion Activated In-Situ Gelling Ophthalmic Solution containing Brimonidine Tartrate using 32 Factorial Design. Research Journal of Pharmacy and Technology. 2024; 17(10):4981-0. doi: 10.52711/0974-360X.2024.00766 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2024-17-10-51
REFERENCES:
1. Shivsharan U S, Hosmani A H, Thorat Y S, Nawale R B. Ion-Sensitive in situ gelling Solution containing Tobramycin for Management of Ocular Infections. Research Journal of Pharmacy and Technology. 2023; 16(9): 4070-4076
2. Aiwale B V, Choudhari B P, Velhal A B, Redasani V K. A review on in situ gel of gastro retentive drug delivery system. Asian Journal of Research in Pharmaceutical Sciences. 2022; 12(4): 314-320
3. Acharya A, Goudanavar P, Vinay C H. Determination of Mucoadhesive behaviour of Timolol maleate liquid crystalline cubogel by different Techniques. Asian Journal of Pharmaceutical Research. 2019; 9(1): 07-11
4. Yasmin A. El-Feky, Ahmed Roshdy Fares, Zayed G, Rania Farag A. El-Telbany, Kawkab A. Ahmed F, Dalia Farag A. El-Telbany. Repurposing of nifedipine loaded in situ ophthalmic gel as a novel approach for glaucoma treatment. Biomedicine and Pharmacotherapy. 2021; 142: 112008
5. Szalai B, Jójárt-Laczkovich O, Kovács A, Berkó S, Balogh T G, Katona G and Budai-Sz M. Design and Optimization of In Situ Gelling Mucoadhesive Eye Drops Containing Dexamethasone. Gels. 2022; 8: 561
6. Thorat Y S, Sarvgod A M, Kulkarni S V. Treatment of Mouth Ulcer by Curcumin Loaded Thermoreversible Mucoadhesive Gel: A Technical Note. International Journal of Pharmacy and Pharmaceutical Sciences. 2015; 7(10): 399-402
7. Kotreka UK, Davis VL, Adeyeye MC. Development of topical ophthalmic In Situ gel forming estradiol delivery system intended for the prevention of age-related cataracts. PLOS One. 2017; 12(2): 1-19
8. Patel DH, Patel MP, Patel MM. Formulation development, optimization and evaluation of once-a-day occuserts of brimonidine tartrate International Research Journal of Pharmacy and Pharmacology.2011; 1(3): 47-054
9. Maiti S, Paul S, Mondol R, Ray S, and Sa B. Nanovesicular Formulation of Brimonidine Tartrate for the Management of Glaucoma: In Vitro and In Vivo Evaluation. American Association of Pharmaceutical Scientists. 2011; 12(2): 755-763
10. Panchal VS, Chilkwar RN, Saboji JK, Patil SM, and Nanjwade BK. Development and Evaluation Ophthalmic in Situ Gel of Betaxolol HCl by Temperature Dependent Method for Treatment of Glaucoma. Journal of Pharmaceutical Sciences and Pharmacology. 2015; 2: 21-25
11. Kalaria VJ, Saisivam S, Alshishani A, Jameel S. Alhesan A, Chakraborty S Rahamathulla M. Design and evaluation of in situ gel eye drops containing nanoparticles of Gemifloxacin Mesylate. Drug Delivery. 2023; 30(1): 2185180
12. Shen T, Yang Z. In vivo and in vitro Evaluation of in situ Gel Formulation of Pemirolast Potassium in Allergic Conjunctivitis. Drug Design, Development and Therapy. 2021; 15: 2099-2107
13. Darwhekar G, Jain P, Jain D K, Agrawal G. Development and optimization of Dorzolamide Hydrochloride and Timolol Maleate in situ Gel for Glaucoma Treatment. Asian Journal of Pharmaceutical Analysis. 2011; 1(4): 93-97
14. Chaturvedi P, Manigauha A. Formulation and Development of Sustained Release of Cefixime using Floating Oral in situ Gelling System. Research Journal of Pharmacy and Technology. 2021; 15(3): 1151-1156
15. Jorapur D, Nagesh C, Suma N, Chandrasekhara S, Attimarad S L, Kengeri S. Ion Sensitive Floating In Situ Gel for Controlled Delivery of Famotidine and DomperidoneMaleate for the Treatment of Gastro Oesophageal Reflux Disease. Research Journal of Pharmacy and Technology. 2017; 11(5): 1984-1989
16. Thorat Y S, Bagewadikar P P, Mali G, Konda K, Nawale R B, Hosmani A H. In Situ Gelling Gastro Retentive Raft Containing Ficus racemosa Fruit Extract: A promising Approach to Treat GERD. Research Journal of Pharmacy and Technology. 2023; 16(8): 3951-3956
17. Abbas MN, Khan SA, Sadozai SK, Khalil IA, Anter A, Fouly M E, Osman AH and Kazi M. Nanoparticles Loaded Thermoresponsive in Situ Gel for Ocular Antibiotic Delivery against Bacterial Keratitis. Polymers. 2022; 14:1135
18. Srivastava S K, Prasad M, Jha A K. Development and Evaluation of Thermo Triggered In Situ Nasal Gel of Selegiline for Depressive Disorders: In Vitro, In Vivo and ex vivo Characterization. Research Journal of Pharmacy and Technology. 2021; 15(4): 1424-1430
19. Soni DA, Shah S and Patel K. Formulation Development and Evaluation of Loteprednol Etabonate and Tobramycin loaded Ocular in situ gel. International Journal of Current Advanced. Research. 2018; 7(4): 11641-11647
20. Kurniawansyah IS, Rusdiana T, Sopyan I, Ramoko H, Wahab HA, Subarnas A. In situ ophthalmic gel forming systems of poloxamer 407 and hydroxypropyl methyl cellulose mixtures for sustained ocular delivery of chloramphenicole: optimization study by factorial design. Heliyon. 2020: 2405-8440
21. Desai A, Pagariya A, Rathod M, Kayande K, Chhajed M, Deokar R, Rai S. Basifloxacin HCL Ophthalmic In Situ gel: Design, Optimization In vitro and Ex vivo Investigation. 2024; 17(5): 2035-2039
22. Khare P, Chogale MM, Kakade P, Patravale VB. Gellan gum–based in situ gelling ophthalmic nanosuspension of Posaconazole. Drug Delivery and Translational Research. 2022; 12: 2920–2935
23. Jagdale S, Shewale N, and Kuchekar BS. Optimization of Thermoreversible in Situ Nasal Gel of Timolol Maleate. Hindawi Publishing Corporation Scientifica. 2016: 1-11.
24. Soni DA, Shah S and Patel K. Formulation Development and Evaluation of Loteprednol Etabonate and Tobramycin loaded Ocular in situ gel. International Journal of Current Advanced Research. 2018; 7(4): 11641-11647
25. Destruel P L, Zeng N, Baudouin FB, Douat S, Seguin J, Olivier E, Dutot M, Rat P, Dufaÿ S, Wojcicki AD, Maury M, Mignet N and Boudy V. In Situ Gelling Ophthalmic Drug Delivery System for the Optimization of Diagnostic and Preoperative Mydriasis: In Vitro Drug Release, Cytotoxicity and Mydriasis Pharmacodynamics. Pharmaceutics. 2020;12: 360
26. Geethalakshmi A, Karki R, Sagi P, Jha SK, Venkatesh. D.P. Temperature Triggered in Situ Gelling System for Betaxolol in Glaucoma. Journal of Applied Pharmaceutical Science. 2013; 3(2): 153-159
27. Remaya P N, Gayathri H, Saraswati T S, Kavitha R, Sangeetha S, Damodharan N. Development and Evaluation of Floating In Situ Gel Solution of Lansoprazole. Journal of Pharmacy Research and Technology. 2017; 10(12): 4323-4327